Results 61 to 70 of about 34,293 (253)
ABSTRACT Background Botulinum toxin Type A (BTX‐A) is increasingly used in the management of myofascial pain; however, the evidence to support this treatment modality is still inconclusive. Objective To evaluate the change in days with functional jaw pain after one session of BTX‐A or placebo injections into the masseter and temporalis muscles in ...
Ava Minston+7 more
wiley +1 more source
The chemical synthesis of orthogonal protected tetra‐ and pentasaccharides combined with chemical sulfation and enzymatic sialylations gave a panel of sulfated ganglio‐oligosaccharides that were printed as microarray and screened for binding to lectins, glycan binding proteins, and antibodies. It revealed that sulfation modulates recognition in complex
Mehman I. Bunyatov+2 more
wiley +2 more sources
Challenging the Clostridium botulinum toxin type A (BoNT/A) with a selection of microorganisms by culture methods and extended storage of used vials to assess the loss of sterility [PDF]
In 2002, botulinum toxin type A (BoNT/A) was approved by the US Food and Drug Administration (FDA) for cosmetic use. However, there may be procedural differences between the ways in which a clinician handles, applies and stores the product compared to ...
Crean, Stjohn+4 more
core
Equine Blood Microbiome in a Cohort of Clinically Healthy Trail Riding Horses
ABSTRACT Background Emerging research suggests the presence of a blood microbiome in clinically healthy individuals. Characterizing bacterial composition and abundance in blood from a group of healthy horses is of clinical interest. Hypothesis/Objectives Horses in a closed herd environment will have blood microbiomes with similarities among individuals.
Noel Simms+4 more
wiley +1 more source
Clostridium botulinum in the Gulf of Thailand [PDF]
A survey was carried out to determine the incidence of Clostridium botulinum in samples of mud, sand, and fish from the Gulf of Thailand. Enrichment cultures from 762 samples of mud and sand from seven different areas around the Gulf were tested. C.
openaire +3 more sources
Safety of Clostridium butyricum TO‐A as a novel food pursuant to Regulation (EU) 2015/2283
Abstract Following a request from the European Commission, the EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA) was asked to deliver an opinion on Clostridium butyricum TO‐A as a novel food (NF) pursuant to Regulation (EU) 2015/2283. The NF, which is proposed by the applicant to be used as a food supplement, is sufficiently characterised ...
EFSA Panel on Nutrition+28 more
wiley +1 more source
Clostridium butyricum, the type species of the genus Clostridium, is considered an obligate anaerobe, yet it has been shown to grow in the presence of oxygen. C. butyricum strains atypically producing the botulinum neurotoxin type E are the leading cause
Serena Camerini+7 more
doaj +1 more source
CLOSTRIDIUM BOTULINUM IN THE SOIL OF PARAGUAY
Seventeen soil samples of Paraguay were examined for the presence of Clostridium botulinum. Botulinum type A, C1 and F toxins were detected in soil cultures. Type E toxin was not detected in any of soil cultures including those from river and lake shores.
Kiyotaka Yamakawa+4 more
openaire +3 more sources
Wetland degradation threatens bird populations, and their intestinal microbiota composition is influenced by local conditions, particularly diet. This pilot study used fecal samples collected from the ground to assess avian gut microbiota via 16S rRNA metabarcoding, revealing significant variations linked to bird traits and environmental factors ...
Laura Fablet+4 more
wiley +1 more source
Botulinum toxin therapy: functional silencing of salivary disorders. [PDF]
Botulinum toxin (BTX) is a neurotoxic protein produced by Clostridium botulinum, an anaerobic bacterium. BTX therapy is a safe and effective treatment when used for functional silencing of the salivary glands in disorders such as sialoceles and salivary ...
Lovato, A+4 more
core